S-CEI of Nexium in paediatric patients
Study identifier:D961WC00002
ClinicalTrials.gov identifier:NCT03562026
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Specific Clinical Experience Investigation of Nexium in paediatric patients
Medical condition
Peptic Ulcer, Gastroesophageal Reflux
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
240
Study type
Observational
Age
N/A
Date
Study Start Date: 28 Jun 2018
Primary Completion Date: 05 Nov 2020
Study Completion Date: 05 Nov 2020
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2021 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Toshihito Nakano
AZKK
